journal article·2020-04-20Open access

Effect of the Tumor Suppressor miR-320a on Viability and Functionality of Human Osteosarcoma Cell Lines Compared to Primary Osteoblasts

Laura De-Ugarte, Susanna Balcells, Robert Guerri-Fernandez, Daniel Grinberg, Adolfo Diez-Perez, Xavier Nogues, Natalia Garcia-Giralt

Applied Sciences· Volume 10· Issue 8

Abstract

The miR-320a regulates a number of genes involved in various physiological processes. In particular, it has been reported as a tumor suppressor in several types of human cancers and involved in osteoporotic fracture and osteoblast function. Hence, the role of miR-320a has been evaluated in tumor cells and in primary cells in a separated context, but its effect has never been explored in a comparative manner. The present study aims to evaluate the cellular effects of miR-320a on human osteosarcoma cell lines (MG-63 and U2OS) compared to that on primary human osteoblasts (hOBs). miR-320a was either overexpressed or inhibited in all cell lines, and cell proliferation and viability were analyzed. Additionally, the effects of miR-320a on matrix mineralization, alkaline phosphatase activity, and oxidative stress were also evaluated in order to assess osteoblast functionality. In osteosarcoma cells, miR-320a overexpression reduced cell viability and proliferation, while in hOB cell viability was not affected and proliferation even was increased. The overexpression of miR-320a in both osteosarcoma cells and hOBs reduced the mineralization capacity. Finally, an increased oxidative stress was detected in all cells after miR-320a overexpression mainly in osteosarcoma. In conclusion, the overexpression of miR-320a increased stress oxidation levels, which could be involved in the reduced osteoblast performance, even though the cell viability was only affected in osteosarcoma cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: MicroRNA in disease regulation · Circular RNAs in diseases · RNA Research and Splicing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Musculoskeletal Research Group, IMIM (Hospital del Mar Medical Research Institute), Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES), ISCIII, 08003 Barcelona, Spain

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Department of Genetics, Microbiology and Statistics, Facultat de Biologia, Universitat de Barcelona, ISCIII, IBUB, IRSJD, 08028 Barcelona, Spain

Funding

Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable · CIBERER · European Regional Development Fund · Instituto de Salud Carlos III

References (24)

Show source-provided references
1. Bone microRNAs and Ageing10.2174/1389201018666170203091828 ↗
2. De-Ugarte, L., Yoskovitz, G., Balcells, S., Guerri-Fernandez, R., Martinez-Diaz, S., Mellibovsky, L., Urreizti, R., Nogues, X., Grinberg, D., and Garcia-Giralt, N. (2015). MiRNA profiling of whole trabecular bone: Identification of osteoporosis-related changes in MiRNAs in human hip bones. BMC Med. Genom., 8.10.1186/s12920-015-0149-2 ↗
3. Diaz-Prado, S., Cicione, C., Muinos-Lopez, E., Hermida-Gomez, T., Oreiro, N., Fernandez-Lopez, C., and Blanco, F.J. (2012). Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet. Disord., 13.10.1186/1471-2474-13-144 ↗
4. MicroRNA-320a protects against osteoarthritis cartilage degeneration by regulating the expressions of BMI-1 and RUNX2 in chondrocytes
5. Liu, G.Z., Chen, C., Kong, N., Tian, R., Li, Y.Y., Li, Z., Wang, K.Z., and Yang, P. (2020). Identification of potential miRNA biomarkers for traumatic osteonecrosis of femoral head. J. Cell Physiol.10.1002/jcp.29467 ↗
6. Lian, F., Cui, Y., Zhou, C., Gao, K., and Wu, L. (2015). Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. PLoS ONE, 10.10.1371/journal.pone.0121499 ↗
7. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor10.3892/ol.2017.5863 ↗
8. MicroRNA-320a downregulation mediates human liver cancer cell proliferation through the Wnt/beta-catenin signaling pathway10.3892/ol.2016.5479 ↗
9. Cheng, C., Chen, Z.Q., and Shi, X.T. (2014). MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase. Tumor Biol.10.1007/s13277-013-1546-9 ↗
10. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a10.1080/15384047.2018.1538612 ↗
11. Wang, Y., Yang, J., Chen, P., Song, Y., An, W., Zhang, H., Butegeleqi, B., and Yan, J. (2020). MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element-binding protein 1. Cancer Med.10.1002/cam4.2919 ↗
12. De-Ugarte, L., Serra-Vinardell, J., Nonell, L., Balcells, S., Arnal, M., Nogues, X., Mellibovsky, L., Grinberg, D., Diez-Perez, A., and Garcia-Giralt, N. (2017). Expression profiling of microRNAs in human bone tissue from postmenopausal women. Hum. Cell.10.1007/s13577-017-0181-y ↗
13. De-Ugarte, L., Balcells, S., Nogues, X., Grinberg, D., Diez-Perez, A., and Garcia-Giralt, N. (2018). Pro-osteoporotic miR-320a impairs osteoblast function and induces oxidative stress. PLoS ONE, 13.10.1371/journal.pone.0208131 ↗
14. MicroRNA-320a Regulates the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Targeting HOXA1010.1159/000438607 ↗
15. Osteogenic differentiation of human ligament fibroblasts induced by conditioned medium of osteoclast-like cells10.5582/bst.2011.v5.2.46 ↗
16. Inhibitory roles of miR-320 in osteosarcoma via regulating E2F110.4103/0973-1482.191635 ↗
17. DIANA-miRPath v3.0: Deciphering microRNA function with experimental support10.1093/nar/gkv403 ↗
18. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer10.1007/s13277-015-4771-6 ↗
19. TGF-beta and BMP signaling in osteoblast differentiation and bone formation10.7150/ijbs.2929 ↗
20. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma10.1007/s11999-015-4578-1 ↗
21. Oxidative stress in bone remodeling: Role of antioxidants10.11138/ccmbm/2017.14.1.209 ↗
22. Sense and sensitivity: FOXO and ROS in cancer development and treatment10.1089/ars.2010.3383 ↗
23. Reactive oxygen species in cancer10.3109/10715761003667554 ↗
24. Increased Oxidative Stress as a Selective Anticancer Therapy10.1155/2015/294303 ↗